Clinical Trials Directory

Trials / Unknown

UnknownNCT01481025

Efficacy and Safety for Cimicifuga/Hypericum Product

Phase 3 Study - Efficacy and Tolerance for the Mixture of Dry Extracts Black Cohosh and Saint John's Worth Versus Isolated Black Cohosh Extract for the Climacteric Symptoms' Control

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
210 (estimated)
Sponsor
Phytopharm Consulting Brazil · Network
Sex
Female
Age
45 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Climacteric Complains bring to women many problems for living a normal life - hot flashes, irritation are 2 of many problems and the mixture of those 2 plant extract must bring a new horizon for this part of time.

Detailed description

2 herbal extracts used in general alone will be running together for the best climacteric women on quality of life. The investigators will test the mixture already in the market as GynoPlus and RemifeminPlus, but as each extract has its own particularities the investigators will try CIM/HIP as a unique formulation versus Clifemin® as control and Aplause® as comparator. This protocol was performed for the best of our volunteers.

Conditions

Interventions

TypeNameDescription
DRUGCimicifuga + Hiperico1 tablet, 80+450mg/tablet, twice a day for 1-3 months 1 tablet, 80+450mg/tablet, once a day for 3-6 months
DRUGCimicifuga Herbarium2 caps, 80mg/caps, once a day for 1-3 months 1 caps, 80mg/caps, once a day for 3-6 months
DRUGAplause®4 tablets, 20mg/tablet, twice a day for 1-3 months 2 tablets, 20mg/tablet, twice a day for 3-6 months

Timeline

Start date
2011-11-01
Primary completion
2012-06-01
Completion
2012-08-01
First posted
2011-11-29
Last updated
2011-11-29

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01481025. Inclusion in this directory is not an endorsement.

Efficacy and Safety for Cimicifuga/Hypericum Product (NCT01481025) · Clinical Trials Directory